Xavier Camous

Xavier Camous

Auto-generated profile, based on publicly available information

Xavier Camous

Biomedical Sciences Institutes, Singapore Immunology Network, A*STAR, 8A Biomedical Grove #4 Immunos Building, Singapore 138648, Singapore

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2009 in Journal of Hepatology
Verified
Journal Article
Closed access
PBPaula Bonorino
Paula Bonorino
MRMuhammad Ramzan
Muhammad Ramzan
XCXavier Camous
Xavier Camous
TDTania Dufeu-Duchesne
Tania Dufeu-Duchesne
MTMarie-Ange Thélu
Marie-Ange Thélu
EJEvelyne Jouvin-Marche
Evelyne Jouvin-Marche

20 November 2012 in Journal of Biomedicine and Biotechnology
Verified
Journal Article
Open access
PDF file
XCXavier Camous
Xavier Camous
Alejandra PeraAlejandra Pera
Alejandra Pera
Rafael SolanaRafael Solana
Rafael Solana
ALAnis Larbi
Anis Larbi
NK cells exhibit the highest cytotoxic capacity within the immune system. Alteration of their number or functionality may have a deep impact on overall immunity. This is of particular relevance in aging where the elderly population becomes more susceptible to infection, cancer, autoimmune diseases, and neurodegenerative diseases amongst others. As the fraction of elderly increases worldwide, it becomes urgent to better understand the aging of the immune system to prevent and cure the elderly population. For this, a better understanding of the function and phenotype of the different immune cells and their subsets is necessary. We review here NK cell functions and phenotype in healthy aging as well as in various age-associated diseases.

11 November 2010 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
DSDamien Sène
Damien Sène
FLFranck Levasseur
Franck Levasseur
MAMichal Abel
Michal Abel
MLMarion Lambert
Marion Lambert
XCXavier Camous
Xavier Camous
SCSophie Caillat-Zucman
Sophie Caillat-Zucman
Understanding how hepatitis C virus (HCV) induces and circumvents the host's natural killer (NK) cell-mediated immunity is of critical importance in efforts to design effective therapeutics. We report here the decreased expression of the NKG2D activating receptor as a novel strategy adopted by HCV to evade NK-cell mediated responses. We show that chronic HCV infection is associated with expression of ligands for NKG2D, the MHC class I-related Chain (MIC) molecules, on hepatocytes. However, NKG2D expression is downmodulated on circulating NK cells, and consequently NK cell-mediated cytotoxic capacity and interferon-γ production are impaired. Using an endotoxin-free recombinant NS5A protein, we show that NS5A stimulation of monocytes through Toll-like Receptor 4 (TLR4) promotes p38- and PI3 kinase-dependent IL-10 production, while inhibiting IL-12 production. In turn, IL-10 triggers secretion of TGFβ which downmodulates NKG2D expression on NK cells, leading to their impaired effector functions. Moreover, culture supernatants of HCV JFH1 replicating Huh-7.5.1 cells reproduce the effect of recombinant NS5A on NKG2D downmodulation. Exogenous IL-15 can antagonize the TGFβ effect and restore normal NKG2D expression on NK cells. We conclude that NKG2D-dependent NK cell functions are modulated during chronic HCV infection, and demonstrate that this alteration can be prevented by exogenous IL-15, which could represent a meaningful adjuvant for therapeutic intervention. Natural killer (NK) cells are part of the innate immune response against virus infection. Their activation is the net result of signals emanating from a panel of inhibitory and activating receptors, among which the NKG2D activating receptor plays a major role. NKG2D ligands, the MHC class I related Chain (MIC) molecules, are induced on HCV-infected hepatocytes. In this paper, we show that NKG2D expression is decreased on NK cells from chronically infected HCV patients. As a consequence, NK cell cytolytic and IFNγ-producing functions are impaired. We show that this phenomenon is mediated by TGFβ produced by monocytes upon stimulation by the non-structural HCV-NS5A protein. NS5A could bind to TLR4 on monocytes, thus inducing the production of IL-10 and TGFβ, while inhibiting the production of IL-12. We further showed that TLR4-dependent IL-10 production by monocytes upon NS5A stimulation was mediated through the p38 and PI3 kinase pathways. In addition, we demonstrated that IL-15 could inhibit the TGFβ-mediated effects on NKG2D expression and NK cell functions. Collectively, these results identify a new dampening signal used by HCV to subvert innate immune response, and may provide new insights into the design of new strategies to restore NK cell functions in chronic hepatitis C.

1 December 2012 in Current Opinion in Immunology
Verified
Journal Article
Closed access
XCXavier Camous
Xavier Camous
SCSebastien Calbo
Sebastien Calbo
DPDamien Picard
Damien Picard
PMPhilippe Musette
Philippe Musette

20 April 2010 in Journal of Hepatology
Verified
Journal Article
Closed access
PDF file
NSNathalie Sturm
Nathalie Sturm
MTMarie-Ange Thélu
Marie-Ange Thélu
XCXavier Camous
Xavier Camous
GDGuéorgui Dimitrov
Guéorgui Dimitrov
MRMuhammad Ramzan
Muhammad Ramzan
EJEvelyne Jouvin-Marche
Evelyne Jouvin-Marche